US Stock MarketDetailed Quotes
ATXI Avenue Therapeutics
- 4.5147
- -1.6853-27.18%
Close Apr 29 16:00 ET
- 4.4982
- -0.0165-0.37%
Post 19:30 ET
2.69MMarket Cap-61P/E (TTM)
5.3500High4.5100Low231.71KVolume5.0700Open6.2000Pre Close1.15MTurnover44.04%Turnover RatioLossP/E (Static)596.00KShares93.750052wk High1.72P/B2.38MFloat Cap4.510052wk Low--Dividend TTM526.19KShs Float13882.2750Historical High--Div YieldTTM13.55%Amplitude4.5100Historical Low4.9510Avg Price1Lot Size
Avenue Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -24.42%-9.45M | 44.26%-2.32M | -60.47%-889K | -394.70%-4.67M | 18.50%-1.57M | -102.56%-7.6M | -246.55%-4.17M | -3.36%-554K | -33.95%-943K | -47.67%-1.93M |
| Net income from continuing operations | -191.09%-10.49M | 17.75%617K | 177.49%513K | -564.90%-4.02M | -165.71%-7.6M | 3.43%-3.6M | 157.39%524K | 24.00%-662K | 36.35%-604K | -186.67%-2.86M |
| Operating gains losses | 23.69%-4.26M | ---2.71M | ---2.57M | --150K | --878K | ---5.58M | ---- | ---- | ---- | ---- |
| Other non cash items | 782.83%4.68M | --377K | --1M | --2M | --1.3M | --530K | ---- | ---- | ---- | ---- |
| Change In working capital | -171.08%-290K | -364.06%-911K | -571.08%-391K | -639.79%-2.83M | 960.22%3.84M | 188.50%408K | 179.68%345K | -68.80%83K | -396.12%-382K | 185.58%362K |
| -Change in receivables | --0 | --13K | --13K | ---13K | -114.44%-13K | 200.00%90K | --0 | --0 | --0 | --90K |
| -Change in prepaid assets | 333.33%70K | 58.12%-49K | -46.32%51K | 1,512.50%129K | -281.25%-61K | -600.00%-30K | -50.00%-117K | 131.71%95K | -83.67%8K | -166.67%-16K |
| -Change in payables and accrued expense | -203.45%-360K | -341.13%-1.11M | -1,700.00%-216K | -654.36%-2.94M | 1,258.33%3.91M | 192.31%348K | 236.28%462K | -104.01%-12K | -587.50%-390K | 169.06%288K |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -24.42%-9.45M | 44.26%-2.32M | -60.47%-889K | -394.70%-4.67M | 18.50%-1.57M | -102.56%-7.6M | -246.55%-4.17M | -3.36%-554K | -33.95%-943K | -47.67%-1.93M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | -3M | 0 | -1M | 0 | 0 | 0 | ||||
| Net intangibles purchase and sale | ---3M | --0 | ---1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | ---3M | --0 | ---1M | ---- | ---- | --0 | --0 | --0 | ---- | ---- |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -28.60%7.53M | -62.98%3.95M | 502.52%479K | 0 | 3.1M | 140.61%10.54M | 143.32%10.66M | -119K | 0 | 0 |
| Net common stock issuance | -27.60%7.53M | -62.72%3.87M | --550K | --0 | --3.1M | 106.05%10.39M | --10.39M | --0 | --0 | --0 |
| Proceeds from stock option exercised by employees | -99.32%1K | ---- | ---- | ---- | ---- | --148K | ---- | ---- | ---- | ---- |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -28.60%7.53M | -62.98%3.95M | 502.52%479K | --0 | --3.1M | 140.61%10.54M | 143.32%10.66M | ---119K | --0 | --0 |
| Net cash flow | ||||||||||
| Beginning cash position | 78.26%6.71M | -25.81%161K | 76.52%1.57M | 349.32%8.24M | 78.26%6.71M | 20.15%3.76M | -62.91%217K | -20.61%890K | 0.44%1.83M | 20.15%3.76M |
| Current changes in cash | -267.23%-4.93M | -75.01%1.62M | -109.51%-1.41M | -606.79%-6.67M | 179.17%1.53M | 366.72%2.95M | 104.25%6.49M | -25.56%-673K | -33.95%-943K | -47.67%-1.93M |
| End cash Position | -73.42%1.78M | -73.42%1.78M | -25.81%161K | 76.52%1.57M | 349.32%8.24M | 78.26%6.71M | 78.26%6.71M | -62.91%217K | -20.61%890K | 0.44%1.83M |
| Free cash flow | -63.92%-12.45M | 44.26%-2.32M | -240.97%-1.89M | -606.79%-6.67M | 18.50%-1.57M | -102.56%-7.6M | -246.55%-4.17M | -3.36%-554K | -33.95%-943K | -47.67%-1.93M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg